Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17515124 | 0.89 | BCHE (0.70) | BCHEACHE | |
| SCHEMBL12903650 | 0.82 | BCHE (0.83) | BCHEACHE | |
| SCHEMBL250421 | 0.81 | ACHE (0.69) | BCHEACHE | |
| Hydrochloric Acid SCHEMBL6704052 | 0.80 | ACHE (0.68) | BCHEACHE | |
| Bromide SCHEMBL1415219 | 0.79 | ACHE (0.72) | BCHEACHE | |
| Iodide SCHEMBL3434358 | 0.79 | ACHE (0.67) | BCHEACHE | |
| Hydrochloric Acid SCHEMBL2578272 | 0.79 | ACHE (0.72) | BCHEACHE | |
| SCHEMBL11148155 | 0.79 | BCHE (0.70) | BCHEACHE | |
| SCHEMBL10005295 | 0.78 | BCHE (1.00) | BCHEACHE | |
| SCHEMBL20151718 | 0.78 | BCHE (1.00) | BCHEACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6977001-B2 | Dye compositions containing quinolinium salts | WELLA AG (DE) | 2005-12-20 | — | — | US | disclosed |
| US-20050107616-A1 | Alpha-ketoamide derivatives as cathepsin k inhibitors | SMITHKLINE BEECHAM CORPORATION | 2005-05-19 | — | — | US | disclosed |
| EP-1143923-B1 | AGENT AND METHOD FOR COLOURING FIBRES | WELLA AG (DE) | 2004-05-06 | — | — | EP | disclosed |
| US-20030177592-A1 | Dye compositions containing quinolinium salts | HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) | 2003-09-25 | — | — | US | disclosed |
| EP-1346719-A1 | Dyeing compositions containing quinolinium salts | Wella Aktiengesellschaft (DE) | 2003-09-24 | — | — | EP | disclosed |
| US-6485529-B1 | Agent and method for coloring fibers | WELLA AKTIENGESELLSCHAFT (DE) | 2002-11-26 | — | — | US | disclosed |
| EP-1143923-A1 | AGENT AND METHOD FOR COLOURING FIBRES | Wella Aktiengesellschaft (DE) | 2001-10-17 | — | — | EP | disclosed |
| WO-2001028507-A1 | AGENT AND METHOD FOR COLOURING FIBRES | WELLA AKTIENGESELLSCHAFT (DE) | 2001-04-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050107616-A1 | Alpha-ketoamide derivatives as cathepsin k inhibitors | CTSK, CTSE, CTSZ | BCHE 571/4885ACHE 2379/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.